Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.

@article{Martiat1991PhiladelphianegativeC,
  title={Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytog{\'e}n{\'e}tique H{\'e}matologique.},
  author={P. Martiat and J. Michaux and J. Rodhain},
  journal={Blood},
  year={1991},
  volume={78 1},
  pages={
          205-11
        }
}
To better understand the Philadelphia-negative (Ph-) chronic myeloid leukemia (CML) and its relationships with Philadelphia-positive (Ph+) CML and chronic myelomonocytic leukemia (CMML), a study was undertaken by the Groupe Français de Cytogénétique Hématologique. Thirty-five Ph- CML patients were investigated and compared with 55 chronic phase Ph+ CML and 100 CMML patients. There were 12 M-BCR positive (M-BCR+) and 23 M-BCR negative (MBCR+) patients. No clinical or biologic differences were… Expand
View on PubMed
ashpublications.org
131 Citations
Highly Influential Citations
3
Background Citations
9
Results Citations
1

131 Citations

Citation Type

Citation Type

BCR rearrangement-negative chronic myelogenous leukemia revisited.
  • 66
Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
  • 28
Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis
  • 7
  • PDF
The cytogenetic scenario of chronic myeloid leukemia.
  • 178
Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome
  • 9
Philadelphia chromosome‐negative chronic myeloid leukaemia: a report of 14 new cases
  • 30
Evidence from molecular genetic and cytogenetic analyses that bone marrow histopathology is reliable in the diagnosis of chronic myeloproliferative disorders
  • 3
Clinical significance of reverse BCR/ABL gene rearrangement in Ph-negative chronic myelogenous leukemia.
  • 5
BCR‐Negative chronic myeloid leukemia in relapse after bone marrow transplantation is susceptible to remission induction by donor lymphocyte infusions
  • 1
Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.
  • 92
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
  • 24
Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
  • 39
Haematological classification of the chronic myeloid leukaemias.
  • 64
Molecular and clinical investigations in Philadelphia chromosome-negative chronic myelogenous leukemia.
  • 13
Genomic diversity correlates with clinical variation in Ph′-negative chronic myeloid leukaemia
  • 143
The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.
  • 94
  • PDF
Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
  • 83
  • PDF
Philadelphia chromosome‐negative chronic myelogenous leukaemia: a morphological reassessment
  • 102
Rearrangement of the bcr gene in Philadelphia-chromosome-negative chronic myeloid leukemia.
  • 105
DO ONCOGENES DETERMINE CLINICAL FEATURES IN CHRONIC MYELOID LEUKAEMIA?
  • 58
...
1
2
3
...